Schonfeld Strategic Advisors LLC Tenaya Therapeutics, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 357,500 shares of TNYA stock, worth $682,825. This represents 0.01% of its overall portfolio holdings.
Number of Shares
357,500
Previous 190,000
88.16%
Holding current value
$682,825
Previous $993,000
11.58%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding TNYA
# of Institutions
98Shares Held
55.6MCall Options Held
30.3KPut Options Held
600-
Column Group LLC San Francisco, CA9.4MShares$18 Million40.92% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.62MShares$14.6 Million0.36% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$12.9 Million1.8% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$7.78 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$6.71 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $79M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...